{"id":39755,"date":"2026-01-28T23:45:19","date_gmt":"2026-01-28T22:45:19","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&#038;p=39755"},"modified":"2026-05-21T22:52:08","modified_gmt":"2026-05-21T20:52:08","slug":"slu-pp-332-300mcg-60-kapselia","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/fi\/shop\/slu-pp-332-300mcg-60-capsules\/","title":{"rendered":"SLU-PP 332 - 300mcg - 100 Kapselia"},"content":{"rendered":"<p data-start=\"0\" data-end=\"67\"><strong data-start=\"0\" data-end=\"67\">SLU-PP-332 - Aineenvaihdunnan aktivointi ja kest\u00e4vyystutkimuskapselit<\/strong><\/p>\n<p data-start=\"69\" data-end=\"337\"><strong data-start=\"69\" data-end=\"85\">Koostumus:<\/strong> SLU-PP-332 (synteettinen pienimolekyylinen aineenvaihdunnan modulaattori)<br \/>\n<strong data-start=\"146\" data-end=\"159\">Kategoria:<\/strong> Metabolinen tutkimusyhdiste<br \/>\n<strong data-start=\"190\" data-end=\"199\">Lomake:<\/strong> Suun kautta otettavat kapselit<br \/>\n<strong data-start=\"216\" data-end=\"228\">Sis\u00e4lt\u00f6:<\/strong> 100 kapselia<br \/>\n<strong data-start=\"243\" data-end=\"256\">Vahvuus:<\/strong> 300 mcg SLU-PP-332 per kapseli<br \/>\n<strong data-start=\"290\" data-end=\"306\">Sovellus:<\/strong> Suullinen tutkimushallinto<\/p>\n<hr data-start=\"339\" data-end=\"342\" \/>\n<h3 data-start=\"344\" data-end=\"367\">Mik\u00e4 on SLU-PP-332?<\/h3>\n<p data-start=\"369\" data-end=\"600\">SLU-PP-332 on <strong data-start=\"385\" data-end=\"412\">uusi tutkimusyhdiste<\/strong> kehitetty kohdentamaan valikoivasti <strong data-start=\"445\" data-end=\"482\">estrogeeniin liittyv\u00e4t reseptorit (ERR)<\/strong>, keskeiset s\u00e4\u00e4ntelij\u00e4t <strong data-start=\"502\" data-end=\"530\">mitokondrioiden biogeneesi<\/strong>, <strong data-start=\"532\" data-end=\"556\">oksidatiivinen aineenvaihdunta<\/strong>, ja <strong data-start=\"562\" data-end=\"599\">kest\u00e4vyyteen liittyv\u00e4t energiareitit<\/strong>.<\/p>\n<p data-start=\"602\" data-end=\"1014\">Toisin kuin stimulantit tai hormonaaliset aineet, SLU-PP-332 toimii stimulanttien tai hormonaalisten aineiden <strong data-start=\"663\" data-end=\"706\">transkriptio- ja mitokondriotaso<\/strong>, mik\u00e4 edist\u00e4\u00e4 aineenvaihduntatilaa, joka on samanlainen kuin <strong data-start=\"747\" data-end=\"780\">kest\u00e4vyysharjoittelun sopeutuminen<\/strong>.<br \/>\nSe on saanut merkitt\u00e4v\u00e4\u00e4 huomiota <strong data-start=\"823\" data-end=\"873\">aineenvaihduntaa, suorituskyky\u00e4 ja pitk\u00e4ik\u00e4isyytt\u00e4 koskeva tutkimus<\/strong> koska se kykenee parantamaan <strong data-start=\"904\" data-end=\"928\">rasvahappojen hapettuminen<\/strong> ja <strong data-start=\"933\" data-end=\"963\">solujen energiatehokkuus<\/strong> ilman suoraa keskushermoston stimulaatiota.<\/p>\n<p data-start=\"1016\" data-end=\"1131\">\u27a1\ufe0f Ihanteellinen seuraavien aiheiden tutkimukseen <strong data-start=\"1041\" data-end=\"1065\">kest\u00e4vyys aineenvaihdunta<\/strong>, <strong data-start=\"1067\" data-end=\"1095\">mitokondrioiden aktivointi<\/strong>, ja <strong data-start=\"1101\" data-end=\"1130\">liikuntaa j\u00e4ljittelev\u00e4t reitit<\/strong>.<\/p>\n<hr data-start=\"1133\" data-end=\"1136\" \/>\n<h3 data-start=\"1138\" data-end=\"1163\">T\u00e4rkeimm\u00e4t tutkimustulokset<\/h3>\n<p data-start=\"1165\" data-end=\"1279\"><strong data-start=\"1165\" data-end=\"1194\">Mitokondrioiden aktivointi:<\/strong> Parantaa mitokondrioiden hapetuskapasiteettia ja energiank\u00e4ytt\u00f6\u00e4 lihasmalleissa.<\/p>\n<p data-start=\"1281\" data-end=\"1381\"><strong data-start=\"1281\" data-end=\"1305\">Kest\u00e4vyysviestint\u00e4:<\/strong> Aktivoi ERR-ohjautuvaa geeniekspressiota, joka liittyy aerobiseen suorituskykyyn.<\/p>\n<p data-start=\"1383\" data-end=\"1467\"><strong data-start=\"1383\" data-end=\"1403\">Rasvan hy\u00f6dynt\u00e4minen:<\/strong> Siirt\u00e4\u00e4 substraatin k\u00e4ytt\u00f6\u00e4 rasvahappojen hapettumisen lis\u00e4\u00e4ntymiseen.<\/p>\n<p data-start=\"1469\" data-end=\"1587\"><strong data-start=\"1469\" data-end=\"1498\">Liikuntaa j\u00e4ljittelev\u00e4t vaikutukset:<\/strong> Aiheuttaa samanlaisia aineenvaihdunnallisia mukautuksia kuin kest\u00e4vyysharjoittelu ilman fyysist\u00e4 rasitusta.<\/p>\n<p data-start=\"1589\" data-end=\"1676\"><strong data-start=\"1589\" data-end=\"1615\">Ei-stimuloiva profiili:<\/strong> Ei vaikuta adrenergisten tai stimulanttipohjaisten mekanismien kautta.<\/p>\n<hr data-start=\"1678\" data-end=\"1681\" \/>\n<h3 data-start=\"1683\" data-end=\"1706\">Toimintamekanismi<\/h3>\n<p data-start=\"1708\" data-end=\"1803\">SLU-PP-332 vaikuttaa ensisijaisesti seuraavasti <strong data-start=\"1756\" data-end=\"1802\">ERR (estrogeenireseptorin) aktivoituminen<\/strong>:<\/p>\n<ul data-start=\"1805\" data-end=\"2119\">\n<li data-start=\"1805\" data-end=\"1887\">\n<p data-start=\"1807\" data-end=\"1887\"><strong data-start=\"1807\" data-end=\"1834\">ERR\u03b1 \/ ERR\u03b3-modulaatio:<\/strong> Edist\u00e4\u00e4 oksidatiiviseen aineenvaihduntaan osallistuvien geenien toimintaa.<\/p>\n<\/li>\n<li data-start=\"1888\" data-end=\"1972\">\n<p data-start=\"1890\" data-end=\"1972\"><strong data-start=\"1890\" data-end=\"1924\">Mitokondrioiden geenien ilmentyminen:<\/strong> Tukee mitokondrioiden tiheytt\u00e4 ja tehokkuutta<\/p>\n<\/li>\n<li data-start=\"1973\" data-end=\"2041\">\n<p data-start=\"1975\" data-end=\"2041\"><strong data-start=\"1975\" data-end=\"2002\">Energiasubstraatin siirtyminen:<\/strong> Edist\u00e4\u00e4 lipidipohjaista energiantuotantoa<\/p>\n<\/li>\n<li data-start=\"2042\" data-end=\"2119\">\n<p data-start=\"2044\" data-end=\"2119\"><strong data-start=\"2044\" data-end=\"2072\">Aineenvaihdunnan uudelleenohjelmointi:<\/strong> Parantaa kest\u00e4vyyteen liittyvi\u00e4 solupolkuja<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"2121\" data-end=\"2124\" \/>\n<h3 data-start=\"2126\" data-end=\"2165\">Annostus ja k\u00e4ytt\u00f6 (tutkimusk\u00e4ytt\u00f6)<\/h3>\n<p data-start=\"2167\" data-end=\"2215\">Tyypillinen tutkimusk\u00e4ytt\u00f6: <strong data-start=\"2189\" data-end=\"2212\">300 mcg per kapseli<\/strong>.<\/p>\n<p data-start=\"2217\" data-end=\"2322\">Yleiset tutkimusprotokollat vaihtelevat <strong data-start=\"2254\" data-end=\"2277\">300-600 mcg p\u00e4iv\u00e4ss\u00e4<\/strong>, tutkimuksen suunnittelusta ja tavoitteista riippuen.<\/p>\n<p data-start=\"2324\" data-end=\"2366\">Hallinnoitu <strong data-start=\"2337\" data-end=\"2363\">suun kautta kapselin muodossa<\/strong>.<\/p>\n<p data-start=\"2368\" data-end=\"2401\">Osoitteessa <strong data-start=\"2372\" data-end=\"2398\">vain tutkimustarkoituksiin<\/strong>.<\/p>\n<hr data-start=\"2403\" data-end=\"2406\" \/>\n<h3 data-start=\"2408\" data-end=\"2432\">S\u00e4ilytysohjeet<\/h3>\n<p data-start=\"2434\" data-end=\"2542\">S\u00e4ilyt\u00e4 <strong data-start=\"2445\" data-end=\"2464\">viile\u00e4ss\u00e4, kuivassa paikassa<\/strong>.<br \/>\nSuojaa l\u00e4mm\u00f6lt\u00e4, valolta ja kosteudelta.<br \/>\nPid\u00e4 s\u00e4ili\u00f6 tiiviisti suljettuna.<\/p>\n<hr data-start=\"2544\" data-end=\"2547\" \/>\n<h3 data-start=\"2549\" data-end=\"2603\">Miksi valita SLU-PP-332-kapselit (300 mcg, 100 kapselia)?<\/h3>\n<p data-start=\"2605\" data-end=\"2756\">SLU-PP-332 edustaa <strong data-start=\"2629\" data-end=\"2679\">uuden sukupolven aineenvaihduntatutkimusyhdisteet<\/strong> kohdistaminen <strong data-start=\"2690\" data-end=\"2732\">kest\u00e4vyys ja mitokondrioiden tehokkuus<\/strong> molekyylitasolla.<\/p>\n<p data-start=\"2758\" data-end=\"2982\">Verrattuna stimuloiviin tai hormonaalisiin reitteihin perustuviin yhdisteisiin SLU-PP-332 tarjoaa <strong data-start=\"2847\" data-end=\"2883\">kohdennettu, ei-stimuloiva l\u00e4hestymistapa<\/strong> opiskeluun <strong data-start=\"2896\" data-end=\"2927\">liikuntaa j\u00e4ljittelev\u00e4 aineenvaihdunta<\/strong>, <strong data-start=\"2929\" data-end=\"2946\">rasvan hapettuminen<\/strong>, ja <strong data-start=\"2952\" data-end=\"2981\">mitokondrioiden suorituskyky<\/strong>.<\/p>\n<p data-start=\"2984\" data-end=\"3158\">The <strong data-start=\"2988\" data-end=\"3034\">100 kapselin muodossa, 300 mcg kapselia kohti.<\/strong> tarjoaa <strong data-start=\"3046\" data-end=\"3110\">tarkka, k\u00e4tev\u00e4 ja tutkimuskelpoinen suun kautta annettava j\u00e4rjestelm\u00e4<\/strong> valvottuja aineenvaihdunta- ja kest\u00e4vyystutkimuksia varten.<\/p>\n<p data-start=\"3160\" data-end=\"3315\" data-is-last-node=\"\" data-is-only-node=\"\">\u2705 <strong data-start=\"3162\" data-end=\"3205\">Tilaa SLU-PP-332 (300 mcg, 100 kapselia)<\/strong> ja tutkia sen mahdollisuuksia <strong data-start=\"3235\" data-end=\"3259\">metabolinen aktivointi<\/strong>, <strong data-start=\"3261\" data-end=\"3283\">kest\u00e4vyystutkimus<\/strong>, ja <strong data-start=\"3289\" data-end=\"3314\">mitokondriotiede<\/strong>.<\/p>","protected":false},"excerpt":{"rendered":"<p>SLU-PP-332 \u2013 Metabolic Activation &amp; Endurance Research Capsules Composition: SLU-PP-332 (synthetic small-molecule metabolic modulator) Category: Metabolic research compound Form: Oral capsules Content: 100 capsules Strength: 300 mcg SLU-PP-332 per capsule Application: Oral research administration What is SLU-PP-332? SLU-PP-332 is a novel research compound developed to selectively target estrogen-related receptors (ERRs), key regulators of mitochondrial biogenesis, oxidative metabolism, and endurance-related energy pathways. Unlike stimulants or hormonal agents, SLU-PP-332 acts at the transcriptional and mitochondrial level, promoting a metabolic state similar to endurance training adaptation. It has gained significant attention in metabolic, performance, and longevity research due to its ability to enhance fatty acid oxidation and cellular energy efficiency without direct central nervous system stimulation. \u27a1\ufe0f Ideal for research on endurance metabolism, mitochondrial activation, and exercise-mimetic pathways. Key Research Insights Mitochondrial Activation: Enhances mitochondrial oxidative capacity and energy utilization in muscle models. Endurance Signaling: Activates ERR-driven gene expression associated with aerobic performance. Fat Utilization: Shifts substrate usage toward increased fatty acid oxidation. Exercise-Mimetic Effects: Induces metabolic adaptations similar to endurance training without physical exertion. Non-Stimulant Profile: Does not act via adrenergic or stimulant-based mechanisms. Mechanism of Action SLU-PP-332 primarily exerts its effects through ERR (Estrogen-Related Receptor) activation: ERR\u03b1 \/ ERR\u03b3 modulation: Upregulates genes involved in oxidative metabolism Mitochondrial gene expression: Supports mitochondrial density and efficiency Energy substrate shift: Favors lipid-based energy production Metabolic reprogramming: Enhances endurance-related cellular pathways Dosage &amp; Application (Research Use) Typical research use: 300 mcg per capsule. Common research protocols range from 300\u2013600 mcg per day, depending on study design and objectives. Administered orally in capsule form. For research purposes only. Storage Instructions Store in a cool, dry place. Protect from heat, light, and moisture. Keep container tightly closed. Why Choose SLU-PP-332 Capsules (300 mcg, 100 Caps)? SLU-PP-332 represents a new generation of metabolic research compounds targeting endurance and mitochondrial efficiency at the molecular level. Compared to compounds that rely on stimulatory or hormonal pathways, SLU-PP-332 offers a targeted, non-stimulant approach to studying exercise-mimetic metabolism, fat oxidation, and mitochondrial performance. The 100-capsule format with 300 mcg per capsule provides a precise, convenient, and research-ready oral delivery system for controlled metabolic and endurance studies. \u2705 Order SLU-PP-332 (300 mcg, 100 capsules) and explore its potential in metabolic activation, endurance research, and mitochondrial science.<\/p>","protected":false},"featured_media":39642,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,25,27],"product_tag":[],"class_list":{"0":"post-39755","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-all-products","7":"product_cat-metabolismandweightmanagement","8":"product_cat-peptidesandresearchdrugs","9":"entry","10":"has-media","12":"first","13":"outofstock","14":"sale","15":"purchasable","16":"product-type-simple"},"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/39755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/comments?post=39755"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/39755\/revisions"}],"predecessor-version":[{"id":47160,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product\/39755\/revisions\/47160"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media\/39642"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/media?parent=39755"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_brand?post=39755"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_cat?post=39755"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/fi\/wp-json\/wp\/v2\/product_tag?post=39755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}